MAXCYTE INC. - COMMON
3.8050
08-أكتوبر-24 12:03:18
15 متأخرة بدقائق
الأسهم
+0.0250
+0.66%
نطاق اليوم
3.7500 - 3.8900
ISIN
N/A
المصدر
NASDAQ
-
16 سبتمبر 2024 01:00:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
05 سبتمبر 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
06 أغسطس 2024 15:05:01 بحسب Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2024 Financial Results on August 6, 2024
09 يوليو 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
29 مايو 2024 07:05:00 بحسب Nasdaq GlobeNewswire
-
22 مايو 2024 07:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
07 مايو 2024 15:05:01 بحسب Nasdaq GlobeNewswire
-
MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024
10 أبريل 2024 07:05:00 بحسب Nasdaq GlobeNewswire
-
02 أبريل 2024 07:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
12 مارس 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results
04 مارس 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
09 فبراير 2024 07:05:00 بحسب Nasdaq GlobeNewswire
-
30 يناير 2024 07:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
23 يناير 2024 07:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
08 يناير 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline
03 يناير 2024 07:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director
02 يناير 2024 01:00:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023
11 ديسمبر 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member
16 نوفمبر 2023 07:05:00 بحسب Nasdaq GlobeNewswire
-
MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance
08 نوفمبر 2023 15:05:01 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >